EP 4106869 A1 20221228 - COLLAGEN HYDROLYSATE AS ACTIVE SUBSTANCE AGAINST PERIODONTITIS OR GINGIVITIS
Title (en)
COLLAGEN HYDROLYSATE AS ACTIVE SUBSTANCE AGAINST PERIODONTITIS OR GINGIVITIS
Title (de)
KOLLAGENHYDROLYSAT ALS WIRKSTOFF GEGEN PARODONTITIS ODER GINGIVITIS
Title (fr)
HYDROLYSAT DE COLLAGÈNE COMME SUBSTANCE ACTIVE CONTRE LA PÉRIODONTITE OU LA GINGIVITE
Publication
Application
Priority
- DE 102020104279 A 20200218
- EP 2020086865 W 20201217
Abstract (en)
[origin: CA3168164A1] The invention relates to a collagen hydrolysate for use as an active substance in the treatment and/or prophylaxis of periodontitis or gingivitis.
IPC 8 full level
A61P 1/02 (2006.01); A61K 38/01 (2006.01); A61K 38/39 (2006.01)
CPC (source: EP KR US)
A61K 38/014 (2013.01 - EP KR US); A61P 1/02 (2017.12 - EP KR US)
Citation (search report)
See references of WO 2021164925A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DE 102020104279 A1 20210819; AU 2020430016 A1 20220825; BR 112022014640 A2 20220913; CA 3168164 A1 20210826; CN 115279457 A 20221101; EP 4106869 A1 20221228; JP 2023515440 A 20230413; KR 20220143012 A 20221024; MX 2022009473 A 20220822; US 2022387545 A1 20221208; WO 2021164925 A1 20210826
DOCDB simple family (application)
DE 102020104279 A 20200218; AU 2020430016 A 20201217; BR 112022014640 A 20201217; CA 3168164 A 20201217; CN 202080096808 A 20201217; EP 2020086865 W 20201217; EP 20839280 A 20201217; JP 2022549539 A 20201217; KR 20227026421 A 20201217; MX 2022009473 A 20201217; US 202217889754 A 20220817